Notice · For research and educational reference. Not medical advice. Intended for licensed professionals. Nothing on this site is offered for sale other than informational access.

All Info Peptides
All monographs

Multi-Peptide Blends

KLOW Blend (GHK-Cu / BPC-157 / TB-500 / KPV)

Also known as · KLOW 80 · GLOW + KPV

Overview

A 50 mg / 10 mg / 10 mg / 10 mg blend extending the GLOW formulation with KPV — the C-terminal tripeptide of α-MSH — studied for anti-inflammatory contribution to combined dermal and soft-tissue regeneration.

Research profile · for clinicians

Based on research: extends the GLOW formulation with KPV — the anti-inflammatory C-terminal fragment of α-MSH — to add NF-κB attenuation and mast-cell stabilization to the copper-peptide and repair-peptide effects of the base blend.

Mechanism of action

Adds KPV's reported NF-κB-attenuating and mast-cell-stabilizing activity to the copper-peptide + BPC-157 + TB-500 regenerative pathways, broadening the inflammation-modulation profile.

Research record

  • [01]KPV anti-inflammatory studies in colitis and dermal models (Brzoska et al.).
  • [02]No published clinical trials of the fixed-ratio quadruple blend.

Selected references

  • α-MSH and its C-terminal tripeptide KPV in inflammation

    Endocr. Rev., 2008